<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03508089</url>
  </required_header>
  <id_info>
    <org_study_id>P15/18_ MS-EYE</org_study_id>
    <nct_id>NCT03508089</nct_id>
  </id_info>
  <brief_title>Exploration of Microcirculatory Alteration and Endothelial Dysfunction by Adaptive Optics in Multiple Sclerosis</brief_title>
  <acronym>MS-EYE</acronym>
  <official_title>Exploration of Microcirculatory Alteration and Endothelial Dysfunction by Adaptive Optics in Multiple Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Versailles Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Versailles Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It's a pilot, interventional prospective monocentric study. It aims to compare the wall /
      lumen ratio (WLR) of retinal arterioles (common marker of microangiopathies) between patients
      with multiple sclerosis and controls using the technique of adaptive optics.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 22, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2018</completion_date>
  <primary_completion_date type="Actual">October 26, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To compare the wall / lumen ratio (WLR) of retinal arterioles (common marker of microangiopathies) between multiple sclerosis patients and controls using the adaptive optics technique.</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare between patients with multiple sclerosis and controls, retinal arteriolar gauges measured by external and internal diameter.</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlate possible changes in arteriolar WLR with internal and external diameter, smoking, age, blood pressure, fatigue (MFIS), cognition (MDT) and disability (EDSS) scores to ambient air and normobaric oxygen.</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Sclerosis, Multiple</condition>
  <arm_group>
    <arm_group_label>Control Arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Multiple Sclerosis Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ocular fundus on patient with Multiple Sclerosis</intervention_name>
    <description>Ocular fundus on patient with Multiple Sclerosis</description>
    <arm_group_label>Multiple Sclerosis Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ocular Fundus on voluntary person</intervention_name>
    <description>Ocular Fundus on voluntary person</description>
    <arm_group_label>Control Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Patient Inclusion Criteria

          -  Major patient between 18 and 50 years

          -  Patient with relapsing or remitting multiple sclerosis defined according to revised Mc
             Donald criteria 2010

          -  Written, free and informed consent dated and signed

          -  Patient affiliated to a social security scheme

        Control Inclusion Criteria:

          -  Person between the ages of 18 and 50

          -  Written, free and informed consent dated and signed

          -  Person affiliated to a social security scheme

          -  Person with multiple sclerosis

        Exclusion Criteria:

          -  Contraindication to the use oxygen (O2): Acute or chronic respiratory insufficiency

          -  Pregnant or lactating woman

          -  Inability to see fundus (cataract), retinopathy, glaucoma

          -  Use of vasoactive substances (eg nasal decongestants, triptans, alkaloids) in the last
             48 hours

          -  Use of nonsteroidal anti-inflammatory drugs (ibuprofen, naproxen, ..) and steroids
             (corticosteroids) in the last 48 hours

          -  Known Diabetes or taking antidiabetics in the last 48 hours

          -  Use of statins in the last 48 hours

          -  Known hypertension or antihypertensive treatment in the last 48 hours

          -  Any cardiac pathology (valvulopathy, angina, ventricular arrhythmia or atrial
             fibrillation), vascular (arteritis obliterating the lower limbs, stenosis of the
             arteries with encephalic destiny, coronary artery disease) or significant respiratory
             (asthma, Chronic obstructive pulmonary disease, interstitial pathology)

          -  Alcohol consumption within 8 hours

          -  Ophthalmoparesis or incapacitating nystagmus (impossibility of correctly evaluating
             the fundus)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CH de Versailles</name>
      <address>
        <city>Le Chesnay</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2018</study_first_submitted>
  <study_first_submitted_qc>April 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2018</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Versailles Hospital</investigator_affiliation>
    <investigator_full_name>Dr Dan BUCH</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

